increased trabecular bone mass_Sost<tm1Paz>/Sost<tm1Paz>

http://metadb.riken.jp/0010872I129SvBlackSwissSosttm1PazSosttm1PazSosttm1Paz

increased trabecular bone mass_Sost<tm1Paz>/Sost<tm1Paz>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• sclerostin
  http://metadb.riken.jp/db/mgi_rdf/MGI:1921749

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Sost<tm1Paz>/Sost<tm1Paz>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Sost<tm1Paz>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129/Sv * Black Swiss

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased trabecular bone mass
  http://purl.obolibrary.org/obo/MP_0010872

文献

http://purl.org/net/cito/citesAsAuthority

• Rajendra. Kedlaya, et.al., Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome., Science translational medicine, 2013, 5
  http://rdf.ncbi.nlm.nih.gov/pubmed/24225945